Clinical trial
Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes
NCT00117780 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00117780 |
|---|---|
| Title | Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes |
| Official title | Comparison of Efficacy and Safety of Insulin Detemir Once or Twice Daily in a Basal-Bolus Regimen With Insulin Aspart in Patients With Type 1 Diabetes |
| Acronym | ADAPT |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin detemir, insulin aspart |
| Enrollment | 520 |
| Start date | Jun 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | Jul 8, 2005 |
| Last update posted | Jun 2, 2017 |
| Countries | Belgium, France, Luxembourg |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: